• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pyrimethamine concentrations in serum and cerebrospinal fluid during treatment of acute Toxoplasma encephalitis in patients with AIDS.

作者信息

Weiss L M, Harris C, Berger M, Tanowitz H B, Wittner M

机构信息

Department of Pathology (Division of Parasitology and Tropical Medicine), Albert Einstein College of Medicine, Bronx, New York.

出版信息

J Infect Dis. 1988 Mar;157(3):580-3. doi: 10.1093/infdis/157.3.580.

DOI:10.1093/infdis/157.3.580
PMID:3343528
Abstract
摘要

相似文献

1
Pyrimethamine concentrations in serum and cerebrospinal fluid during treatment of acute Toxoplasma encephalitis in patients with AIDS.
J Infect Dis. 1988 Mar;157(3):580-3. doi: 10.1093/infdis/157.3.580.
2
Sulfadiazine crystalluria revisited. The treatment of Toxoplasma encephalitis in patients with acquired immunodeficiency syndrome.
Arch Intern Med. 1990 Nov;150(11):2379-84. doi: 10.1001/archinte.150.11.2379.
3
Sulfadiazine-induced crystalluria in AIDS patients with toxoplasma encephalitis.
AIDS. 1991 May;5(5):587-9.
4
Toxoplasma encephalitis in patients with acquired immune deficiency syndrome: diagnosis and response to therapy.获得性免疫缺陷综合征患者的弓形虫脑炎：诊断及对治疗的反应
Am J Trop Med Hyg. 1987 May;36(3):509-16. doi: 10.4269/ajtmh.1987.36.509.
5
Determination of the inhibitory effect on Toxoplasma growth in the serum of AIDS patients during acute therapy for toxoplasmic encephalitis.
J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Sep 1;19(1):50-4. doi: 10.1097/00042560-199809010-00008.
6
Cerebral toxoplasmosis in the acquired immune deficiency syndrome.获得性免疫缺陷综合征中的脑弓形虫病
Clin Neurol Neurosurg. 1989;91(4):291-301. doi: 10.1016/0303-8467(89)90004-8.
7
Toxoplasmic encephalitis.
AIDS. 1990 Jun;4(6):593-5. doi: 10.1097/00002030-199006000-00018.
8
Long-term follow-up of patients with AIDS on maintenance therapy for toxoplasmosis.接受弓形虫病维持治疗的艾滋病患者的长期随访
Eur J Clin Microbiol Infect Dis. 1991 Mar;10(3):191-3. doi: 10.1007/BF01964460.
9
AIDS commentary. Toxoplasmic encephalitis.艾滋病评论。弓形体脑炎。
J Infect Dis. 1988 Jan;157(1):1-6. doi: 10.1093/infdis/157.1.1.
10
Treatment of acute toxoplasmosis with intravenous clindamycin. The California Collaborative Treatment Group.
Eur J Clin Microbiol Infect Dis. 1991 Mar;10(3):193-5. doi: 10.1007/BF01964461.

引用本文的文献

1
Case Report: Immune Dysregulation Due to Reactivation After Allogeneic Hematopoietic Cell Transplant.病例报告：异基因造血细胞移植后再激活导致的免疫失调
Front Pediatr. 2021 Aug 10;9:719679. doi: 10.3389/fped.2021.719679. eCollection 2021.
2
Sulfadiazine plasma concentrations in women with pregnancy-acquired compared to ocular toxoplasmosis under pyrimethamine and sulfadiazine therapy: a case-control study.妊娠合并与弓形虫眼病患者比较的磺胺嘧啶血浆浓度：一项病例对照研究。
Eur J Med Res. 2020 Nov 23;25(1):59. doi: 10.1186/s40001-020-00458-7.
3
Systemic and Target-Site Pharmacokinetics of Antiparasitic Agents.
抗寄生虫药物的全身和作用部位药代动力学。
Clin Pharmacokinet. 2020 Jul;59(7):827-847. doi: 10.1007/s40262-020-00871-5.
4
Effect of cyclic, low dose pyrimethamine treatment in patients with Late Onset Tay Sachs: an open label, extended pilot study.环磷酰胺低剂量治疗晚发性泰-萨克斯病患者的疗效：一项开放标签的扩展试点研究。
Orphanet J Rare Dis. 2015 Apr 17;10:45. doi: 10.1186/s13023-015-0260-7.
5
Chaperone therapy for GM2 gangliosidosis: effects of pyrimethamine on β-hexosaminidase activity in Sandhoff fibroblasts.GM2神经节苷脂贮积症的伴侣蛋白疗法：乙胺嘧啶对桑德霍夫成纤维细胞中β-己糖胺酶活性的影响
Mol Neurobiol. 2014 Aug;50(1):159-67. doi: 10.1007/s12035-013-8605-5. Epub 2013 Dec 20.
6
Intravitreal clindamycin plus dexamethasone versus classic oral therapy in toxoplasmic retinochoroiditis: a prospective randomized clinical trial.玻璃体内注射克林霉素联合地塞米松与经典口服疗法治疗弓形虫性视网膜脉络膜炎的前瞻性随机临床试验
Int Ophthalmol. 2013 Feb;33(1):39-46. doi: 10.1007/s10792-012-9634-1. Epub 2012 Sep 28.
7
Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections.药物穿透血脑屏障/血脑脊液屏障以治疗中枢神经系统感染。
Clin Microbiol Rev. 2010 Oct;23(4):858-83. doi: 10.1128/CMR.00007-10.
8
An open-label Phase I/II clinical trial of pyrimethamine for the treatment of patients affected with chronic GM2 gangliosidosis (Tay-Sachs or Sandhoff variants).吡嘧司特治疗慢性 GM2 神经节苷脂病（Tay-Sachs 或桑德霍夫变异型）患者的开放标签 I/II 期临床试验。
Mol Genet Metab. 2011 Jan;102(1):6-12. doi: 10.1016/j.ymgme.2010.09.004. Epub 2010 Sep 17.
9
Screening for inhibitors of the SOD1 gene promoter: pyrimethamine does not reduce SOD1 levels in cell and animal models.筛选 SOD1 基因启动子抑制剂：乙胺嘧啶不会降低细胞和动物模型中的 SOD1 水平。
Neurosci Lett. 2010 Oct 4;482(3):188-92. doi: 10.1016/j.neulet.2010.07.020. Epub 2010 Jul 16.
10
Kinetics of pyrimethamine in young and adult rats on a standard diet and on a low-protein diet.乙胺嘧啶在标准饮食和低蛋白饮食条件下对幼龄和成年大鼠的动力学研究。
Eur J Drug Metab Pharmacokinet. 2009 Jul-Sep;34(3-4):173-6. doi: 10.1007/BF03191170.